Israel moves to decrease drug misuse
This article was originally published in SRA
Executive Summary
The Pharmaceutical Administration in Israel has issued a new guideline specifying the conditions for the dispensing and marketing of medicinal products containing restricted ingredients, ie active ingredients with a potential for misuse1. The guideline applies specifically to products containing codeine and ephedrine/pseudoephedrine.